Prognostic significance and biological function of SOCS3 in bladder cancer

Author:

Zhou Hui1,Chen Liuxi1,Liu Ying1,Zhang Ruonan2,Chen Bi1,Feng Jiao2,Liu Shuiping2,Xiang Yu2,Zhang Mingming2,Duan Ting2,Zhang Wenzheng3,Tang Huifen1,Yang Zuyi1,Chen Xiaohui1,Gu Lei1,Zhang Qi3

Affiliation:

1. the Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University

2. Hangzhou Normal University

3. Zhejiang Provincial People’s Hospital, Hangzhou Medical College

Abstract

Abstract Background: Suppressor of cytokine signaling (SOCS) is a family of proteins that respond to cytokine, growth factors and other signals, and can regulate various functions of tumor cells. The purpose of our study was to investigate the prognostic performance and biological function of SOCS3 in bladder cancer. Methods: The clinical information of 80 patients with bladder cancer at Zhejiang Provincial People’s Hospital was collected and the SOCS3 protein level was detected by immunohistochemistry. The relationship between SOCS3 status and clinical parameters and the prognosis was analyzed. Besides, we explored the biological function of SOCS3 in bladder cancer. Results: The expression of SOCS3 in bladder cancer tissues was lower than that in normal tissues at the protein level and transcription level (P < 0.001). The low expression group of SOCS3 was more inclined to high staging and high grading. The prognosis of the high expression group of SOCS3 was significantly better than that of the low expression group of SOCS3 in non-muscle-invasive bladder cancer patients (P = 0.037). Also, ectopic expression of SOCS3 reduced the cell proliferation and migration ability of the bladder cancer cell line. Conclusions: Our findings imply that SOCS3 is a potential prognostic factor for non-muscle-invasive bladder cancer, and plays a tumor suppressor role in bladder cancer.

Publisher

Research Square Platform LLC

Reference28 articles.

1. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020;Qiu H;Cancer communications (London, England),2021

2. Epidemiology and risk factors of urothelial bladder cancer;Burger M;European urology,2013

3. Bladder cancer;Sanli O;Nature reviews Disease primers,2017

4. Lindgren D, Liedberg F, Andersson A, Chebil G, Gudjonsson S, Borg A, Mansson W, Fioretos T, Hoglund M: Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q. Oncogene 2006, 25(18):2685–2696.

5. Pathology of upper tract urothelial carcinoma with emphasis on staging;Mazzucchelli R;International journal of immunopathology and pharmacology,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3